Clinical Impact of Baseline ctDNA RAS/BRAF Mutations on Conversion Surgery and Outcomes in First-Line Anti-EGFR Therapy for Advanced Colorectal Cancer.
- DOI
- 10.3390/cancers18111688
- Published
- 2026 May 22
- Container
- Cancers
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/cancers18111688,
title = {Clinical Impact of Baseline ctDNA RAS/BRAF Mutations on Conversion Surgery and Outcomes in First-Line Anti-EGFR Therapy for Advanced Colorectal Cancer.},
author = {Yamada T and Nagasaka T and Matsuhashi N and Takahashi T and Hirata K and Nakamura Y and Sugimoto K and Koda K and Hiramatsu K and Matsuoka H and Kuramochi H and Matsuda A and Ishida H and Kataoka K and Yokomizo H and Kagawa Y and Suenaga M and Yoshida H},
year = {2026},
journal = {Cancers},
doi = {10.3390/cancers18111688},
url = {https://doi.org/10.3390/cancers18111688}
}RIS
TY - JOUR TI - Clinical Impact of Baseline ctDNA RAS/BRAF Mutations on Conversion Surgery and Outcomes in First-Line Anti-EGFR Therapy for Advanced Colorectal Cancer. AU - Yamada T AU - Nagasaka T AU - Matsuhashi N AU - Takahashi T AU - Hirata K AU - Nakamura Y AU - Sugimoto K AU - Koda K AU - Hiramatsu K AU - Matsuoka H AU - Kuramochi H AU - Matsuda A AU - Ishida H AU - Kataoka K AU - Yokomizo H AU - Kagawa Y AU - Suenaga M AU - Yoshida H PY - 2026 JO - Cancers DO - 10.3390/cancers18111688 UR - https://doi.org/10.3390/cancers18111688 ER -
APA
T, Y., T, N., N, M., T, T., K, H., Y, N., K, S., K, K., K, H., H, M., H, K., A, M., H, I., K, K., H, Y., Y, K., M, S., & H, Y. (2026). Clinical Impact of Baseline ctDNA RAS/BRAF Mutations on Conversion Surgery and Outcomes in First-Line Anti-EGFR Therapy for Advanced Colorectal Cancer.. Cancers. https://doi.org/10.3390/cancers18111688
Source records
- pubmed · retrieved 2026-09-26T15:51:09.974Z